Free Trial

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Announces $0.10 Dividend

CochLear logo with Medical background

Key Points

  • CochLear Ltd. Unsponsored ADR has announced a dividend of $0.10 per share, with stockholders of record on September 22nd set to receive it on October 28th.
  • The stock is currently showing a dividend yield of 122.0%, with an ex-dividend date of September 19th.
  • Cochlear Limited specializes in implantable hearing solutions and has seen stock prices range from a twelve-month low of $74.76 to a high of $105.60.
  • Interested in CochLear? Here are five stocks we like better.

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) declared a dividend on Tuesday, September 16th, investing.com reports. Shareholders of record on Monday, September 22nd will be paid a dividend of 0.1045 per share on Tuesday, October 28th. This represents a yield of 122.0%. The ex-dividend date of this dividend is Friday, September 19th.

CochLear Trading Down 3.3%

CHEOY stock traded down $3.30 during mid-day trading on Friday, hitting $96.55. 5,489 shares of the company were exchanged, compared to its average volume of 6,484. The business has a fifty day simple moving average of $99.81 and a 200-day simple moving average of $91.68. CochLear has a 12-month low of $74.76 and a 12-month high of $105.60.

CochLear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Featured Stories

Dividend History for CochLear (OTCMKTS:CHEOY)

Should You Invest $1,000 in CochLear Right Now?

Before you consider CochLear, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.

While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.